Registrational results of LIBRETTO-001: A phase 1/2 trial of LOXO-292 in patients with RET fusion-positive lung cancers Meeting Abstract


Authors: Drilon, A.; Oxnard, G.; Wirth, L.; Besse, B.; Gautschi, O.; Tan, S. W. D.; Loong, H.; Bauer, T.; Kim, Y. J.; Horiike, A.; Park, K.; Shah, M.; McCoach, C.; Bazhenova, L.; Seto, T.; Brose, M.; Pennell, N.; Weiss, J.; Matos, I.; Peled, N.; Cho, B. C.; Ohe, Y.; Reckamp, K.; Boni, V.; Satouchi, M.; Falchook, G.; Akerley, W.; Daga, H.; Sakamoto, T.; Patel, J.; Lakhani, N.; Barlesi, F.; Burkard, M.; Zhu, V.; Moreno Garcia, V.; Medioni, J.; Matrana, M.; Rolfo, C.; Lee, D. H.; Nechushtan, H.; Johnson, M.; Velcheti, V.; Nishio, M.; Toyozawa, R.; Ohashi, K.; Song, L.; Han, J.; Spira, A.; De Braud, F.; Staal Rohrberg, K.; Takeuchi, S.; Sakakibara, J.; Waqar, S.; Kenmotsu, H.; Wilson, F.; Nair, B.; Olek, E.; Kherani, J.; Ebata, K.; Zhu, E.; Nguyen, M.; Yang, L.; Huang, X.; Cruickshank, S.; Rothenberg, S.; Solomon, B.; Goto, K.; Subbiah, V.
Abstract Title: Registrational results of LIBRETTO-001: A phase 1/2 trial of LOXO-292 in patients with RET fusion-positive lung cancers
Meeting Title: 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords: nsclc; ret fusion; selective ret inhibitor
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 7-10
Meeting Location: Barcelona, Spain
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: S6
End Page: S7
Language: English
ACCESSION: WOS:000492162200010
DOI: 10.1016/j.jtho.2019.08.059
PROVIDER: wos
Notes: Meeting Abstract: PL02.08 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon
  2. Joshua Weiss
    14 Weiss